Search results for ''
The Liver Meeting 2015 – AASLD
13 – 17 November 2015
U.S.A, San Francisco, California
More than 9,500 hepatologists and hepatology health professionals from across the nation and around the world gather at The Liver Meeting® to exchange the latest liver diseases research, discuss treatment outcomes, and interact with colleagues at the annual must-attend even in the science and practice of hepatology.
poster AASLD_P.Andre_Poster_2_2015
Max-Planck – Focus Symposium – Host-directed therapy : New ways to curing infections
November 16th to 17th, 2015
Berlin
The aim of the conference is to bring together pioneers in this emerging research area, discuss their most recent findings and future applications, as well as potential constraints of the approach for medical use. To this end, key scientists in the field as well as experts from the pharmaceutical industries will present their latest results and provide their views on the importance of new treatment strategies.
2015 International HBV Meeting – The Molecular Biology of Hepatitis B Viruses
October 4, 2015 – October 8, 2015
Bad Nauheim, Germany
The International Meeting of the Molecular Biology of Hepatitis B Viruses remains the definitive international meeting that covers all aspects of the biology of hepatitis B and hepatitis D, including biochemistry, molecular biology, traditional virology, immunology, pathogenesis, and carcinogenesis, as well as the latest developments in antiviral therapies against these two viruses.
Pr P. André’s talk : “Reciprocal effect of HBV infection and FXR activation on the expression of FXR controlled genes”.
Board
Board members
Jacky Vonderscher, PhD, Chief Executive Officer and Chairman of the Board
- Founder of Vonderscher&Co GmbH
- Senior executive with a broad R&D experience in the pharmaceutical industry
- Most recently Senior VP Head of Translation Research Sciences at Roche in USA and Switzerland (2010-2012)
- Senior VP head of Molecular Medicine Labs at Roche (2008-2010)
- Previously held other senior positions with Novartis in the USA and Switzerland (1979 to 2008)
- Known for his leading role in the discovery and development of Sandimmum Neoral® in the 90s
- Co-inventor on the first patents of Mycophenolic Acid Sodium salt (Myfortic® Product) and of Everolimus (Certican® and Afinitor® Products)
- Board member of Inatherys,
EASL – The International Liver Congress 2016
13-17 April 2016
Barcelona, Spain
Every year in April, scientific and medical experts from a broad range of fields including hepatology, gastroenterology, internal medicine, cell biology, transplant surgery, infectious diseases, microbiology and virology, pharmacology, pathology and radiology and imaging come together from around the world to learn about the latest in liver research.
Latest Press Release 